Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V 2025-07-08 10:02
WuXi AppTec Receives MSCI ESG AAA Leader Rating 2025-07-07 20:08
Nuevocor Strengthens Board with Appointment of Thierry Abribat 2025-07-07 13:00
ESG | HitGen Releases Its Inaugural Sustainability Report 2025-07-04 19:00
Everest Medicines Showcases Breakthroughs in Proprietary AI-Powered mRNA Platform at 2025 R&D Day Held in Shanghai 2025-07-04 16:58
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China 2025-07-04 08:30
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results 2025-07-03 20:30
MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform 2025-07-03 18:07
So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement 2025-07-03 17:00
Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy 2025-07-03 14:46
Novotech Earns Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services 2025-07-03 13:30
Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2025-07-03 08:08
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 2025-07-03 07:09
SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response 2025-07-02 23:00
Bon Announces Breakthrough Order for $16 Million Gut-Health Products 2025-07-02 20:00
[iNtRON] Files U.S. Patent for Three Novel Endolysin-Based Drug Candidates Targeting Gram-Negative Bacteria 2025-07-02 20:00
Arbele Wins Top Prize at BCIC's 4th Annual Biomedical Pitch Competition 2025-07-02 16:19
Everest Medicines Announces Updated Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy 2025-07-02 15:33
Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics 2025-07-01 22:09
Metabolon's Untargeted Metabolomics Services Used for Breakthrough Study Revealing Powerful Link Between Gut Microbiome, the Metabolome, and Type 2 Diabetes (T2D) 2025-07-01 21:00
1 31 32 33 34 35 525